Vertex Pharmaceuticals Inc
Close on Nov 18, 2026Market cap $135.97BP/E 31.2Yield –
Vertex Pharmaceuticals U.S. Producer Price Index (PPI) by Quarter
U.S. Producer Price Index (PPI) — Pharmaceutical Preparation Manufacturing (PCU325412325412, index)
Vertex Pharmaceuticals U.S. Producer Price Index (PPI): 926.20 in Q2 2026, up 1.2% from a year earlier. That is the highest of the 46 quarters on record here.
Where the Q2 2026 figure comes from
Source: FRED (PCU325412325412) ↗
Reported in FRED / BLS / BEA / U.S. Census Bureau Healthcare & Pharmaceutical Benchmarks.
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | U.S. Producer Price Index (PPI) — Pharmaceutical Preparation Manufacturing (PCU325412325412, index) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 926.20 | +1.2% | FRED (PCU325412325412) ↗ |
| Q1 2026 | Mar 31, 2026 | 926.00 | +1.0% | FRED (PCU325412325412) ↗ |
| Q4 2025 | Dec 31, 2025 | 919.30 | +0.1% | FRED (PCU325412325412) ↗ |
| Q3 2025 | Sep 30, 2025 | 918.70 | +0.1% | FRED (PCU325412325412) ↗ |
| Q2 2025 | Jun 30, 2025 | 914.80 | +0.1% | FRED (PCU325412325412) ↗ |
| Q1 2025 | Mar 31, 2025 | 916.50 | +0.8% | FRED (PCU325412325412) ↗ |
| Q4 2024 | Dec 31, 2024 | 918.50 | +2.5% | FRED (PCU325412325412) ↗ |
| Q3 2024 | Sep 30, 2024 | 918.10 | +2.5% | FRED (PCU325412325412) ↗ |
| Q2 2024 | Jun 30, 2024 | 914.00 | +2.2% | FRED (PCU325412325412) ↗ |
| Q1 2024 | Mar 31, 2024 | 909.00 | +1.7% | FRED (PCU325412325412) ↗ |
| Q4 2023 | Dec 31, 2023 | 896.40 | +3.1% | FRED (PCU325412325412) ↗ |
| Q3 2023 | Sep 30, 2023 | 896.00 | +3.0% | FRED (PCU325412325412) ↗ |
| Q2 2023 | Jun 30, 2023 | 894.00 | +3.5% | FRED (PCU325412325412) ↗ |
| Q1 2023 | Mar 31, 2023 | 893.90 | +5.2% | FRED (PCU325412325412) ↗ |
| Q4 2022 | Dec 31, 2022 | 869.50 | +4.2% | FRED (PCU325412325412) ↗ |
| Q3 2022 | Sep 30, 2022 | 869.70 | +4.4% | FRED (PCU325412325412) ↗ |
| Q2 2022 | Jun 30, 2022 | 864.00 | +3.4% | FRED (PCU325412325412) ↗ |
| Q1 2022 | Mar 31, 2022 | 849.40 | +1.7% | FRED (PCU325412325412) ↗ |
| Q4 2021 | Dec 31, 2021 | 834.50 | +1.7% | FRED (PCU325412325412) ↗ |
| Q3 2021 | Sep 30, 2021 | 833.10 | +1.6% | FRED (PCU325412325412) ↗ |
| Q2 2021 | Jun 30, 2021 | 835.50 | +1.4% | FRED (PCU325412325412) ↗ |
| Q1 2021 | Mar 31, 2021 | 835.10 | +1.1% | FRED (PCU325412325412) ↗ |
| Q4 2020 | Dec 31, 2020 | 820.30 | +1.0% | FRED (PCU325412325412) ↗ |
| Q3 2020 | Sep 30, 2020 | 820.30 | +0.9% | FRED (PCU325412325412) ↗ |
| Q2 2020 | Jun 30, 2020 | 823.90 | +1.8% | FRED (PCU325412325412) ↗ |
| Q1 2020 | Mar 31, 2020 | 825.80 | +1.9% | FRED (PCU325412325412) ↗ |
| Q4 2019 | Dec 31, 2019 | 811.90 | +1.9% | FRED (PCU325412325412) ↗ |
| Q3 2019 | Sep 30, 2019 | 813.10 | +3.1% | FRED (PCU325412325412) ↗ |
| Q2 2019 | Jun 30, 2019 | 809.70 | +3.2% | FRED (PCU325412325412) ↗ |
| Q1 2019 | Mar 31, 2019 | 810.80 | +3.6% | FRED (PCU325412325412) ↗ |
| Q4 2018 | Dec 31, 2018 | 796.40 | +4.1% | FRED (PCU325412325412) ↗ |
| Q3 2018 | Sep 30, 2018 | 788.40 | +4.6% | FRED (PCU325412325412) ↗ |
| Q2 2018 | Jun 30, 2018 | 784.70 | +3.4% | FRED (PCU325412325412) ↗ |
| Q1 2018 | Mar 31, 2018 | 783.00 | +4.7% | FRED (PCU325412325412) ↗ |
| Q4 2017 | Dec 31, 2017 | 765.40 | +5.9% | FRED (PCU325412325412) ↗ |
| Q3 2017 | Sep 30, 2017 | 753.50 | +4.6% | FRED (PCU325412325412) ↗ |
| Q2 2017 | Jun 30, 2017 | 758.60 | +6.0% | FRED (PCU325412325412) ↗ |
| Q1 2017 | Mar 31, 2017 | 748.10 | +6.0% | FRED (PCU325412325412) ↗ |
| Q4 2016 | Dec 31, 2016 | 723.00 | +7.2% | FRED (PCU325412325412) ↗ |
| Q3 2016 | Sep 30, 2016 | 720.60 | +7.4% | FRED (PCU325412325412) ↗ |
| Q2 2016 | Jun 30, 2016 | 715.60 | +6.9% | FRED (PCU325412325412) ↗ |
| Q1 2016 | Mar 31, 2016 | 706.00 | +9.3% | FRED (PCU325412325412) ↗ |
| Q4 2015 | Dec 31, 2015 | 674.30 | – | FRED (PCU325412325412) ↗ |
| Q3 2015 | Sep 30, 2015 | 670.80 | – | FRED (PCU325412325412) ↗ |
| Q2 2015 | Jun 30, 2015 | 669.50 | – | FRED (PCU325412325412) ↗ |
| Q1 2015 | Mar 31, 2015 | 646.20 | – | FRED (PCU325412325412) ↗ |
Breakdown
What makes up U.S. Producer Price Index (PPI)
- U.S. PPI — Biological Product (ex-Diagnostic) Manufacturing (PCU325414325414, index)266.30 · Q2 2026
- U.S. PPI — Pharmaceutical & Medicine Manufacturing (PCU3254132541, index)245.70 · Q2 2026
- U.S. Consumer Price Index (CPI-U) — Medical Care Commodities, Seasonally Adjusted (CUSR0000SAM1, index)409.00 · Q2 2026
- U.S. CPI-U — Medical Care Commodities, Not Seasonally Adjusted (CUUR0000SAM1, index)409.00 · Q2 2026
- U.S. CPI-U — Medical Care, Seasonally Adjusted (CPIMEDSL, index)592.30 · Q2 2026
- U.S. Retail Sales — Pharmacies and Drug Stores, Seasonally Adjusted (MRTSSM44611USS, $M)–
- U.S. Retail Sales — Pharmacies and Drug Stores, Not Seasonally Adjusted (MRTSSM44611USN, $M)–
- U.S. Real Personal Consumption Expenditures — Health Care Services (DHLCRC1Q027SBEA, $B SAAR)3,790.30 · Q2 2026
- U.S. Employment — Health Care & Social Assistance All Employees (CES6562000001, thousands)23,887.20 · Q2 2026
Cite this data
StockData. (2026). Vertex Pharmaceuticals U.S. Producer Price Index (PPI), quarterly Q1 2015–Q2 2026 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/macro-pharma-hdr
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.
See a number that looks wrong?